Drug
Aprotinin clinical trials
- studies test it
- 10
- open now
- 1
- in phase 3
- 5
- first study started
- 2003
Keep track of what changes. Save the Aprotinin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2020 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 3
- 5
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 4
Bayer (4) · Imperial College London (1) · Nycomed (1) · Nemours Children's Clinic (1) · Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion (1) · Dartmouth-Hitchcock Medical Center (1) · Aviron LLC (1)
Studies
Open first, then newest update. How each study uses Aprotinin is read from its arms, and is right about nine times in ten.
Testing it · 10
- Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome TreatmentRecruitingPhase 3Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la IntegracionNCT07317050Written as Aprotinin (inhaled)
- An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19Status unknownNot applicableAviron LLCNCT04527133Written as Aprotinin
- Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion SurgeryTerminatedPhase 3BayerNCT00327379Written as Trasylol (Aprotinin, BAYA0128)
- Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary BypassCompletedNot applicableImperial College LondonNCT00131040Written as Aprotinin
- Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip ReplacementCompletedPhase 3BayerNCT00668031Written as Trasylol (Aprotinin, BAYA0128)
- Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total CystectomyTerminatedPhase 3BayerNCT00306150Written as Trasylol (Aprotinin, BAYA0128)
- Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal CancerTerminatedPhase 3BayerNCT00306137Written as Trasylol (Aprotinin, BAYA0128)
- Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)CompletedPhase 4NycomedNCT00290836Written as Human fibrinogen/thrombin and bovine aprotinin (TachoComb H)
- Can Aprotinin Reduce Pancreatitis After Scoliosis SurgeryCompletedPhase 1Nemours Children's ClinicNCT00357851Written as Aprotinin
- Phase I Study of Aprotinin in Advanced Breast CancerTerminatedPhase 1Dartmouth-Hitchcock Medical CenterNCT00354900Written as Aprotinin
Codes
What other systems call Aprotinin · ClinicalTrials.gg INT007703
- MeSH (NLM) D007611AprotininConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 04XPW8C0FLAPROTININConfirmed FDA, Wikidata
- RxNorm 1056Confirmed FDA, Wikidata
- Wikidata Q418625aprotininConfirmed FDA, Wikidata
- NCI Thesaurus C47402AprotininOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007611 | Aprotinin | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 04XPW8C0FL | APROTININ | Confirmed FDA, Wikidata |
| RxNorm | 1056 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418625 | aprotinin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C47402 | Aprotinin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.